Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year’s End 0 19.02.2019 03:00 Feedity.com Teva Pharmaceuticals is expecting big things from its generic EpiPen. The company snagged approval for its generic version of Mylan’s EpiPen Auto-Injector in August 2018. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
